- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05388422
Application of 3D Scanner to Measure Physical Size in Patients With Severe Cerebral Palsy
April 27, 2023 updated by: Ju Seok Ryu, Seoul National University Hospital
Physical Measurement in Patients With Severe Cerebral Palsy Using 3D Scanner and Improvement of Manufacturing Techniques for Hip Dislocation Prevention Assistive Devices
The aim of this study is to improve the manufacturing techniques of hip brace in preventing progressive hip displacement in patients with severe cerebral palsy, through the measurement of patient's physical size using a 3D scanner.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
- Design : Prospective Study
- Setting: Hospital rehabilitation department and Home
- Intervention: Before starting the study, radiologic and clinical evaluation were performed. After measuring the patient's exact physical size by applying a 3D scanner, we manufacture hip brace in preventing progressive hip displacement in patients with severe cerebral palsy. After wearing for a week, follow-up radiologic and clinical evaluation were performed.
- Main outcome measure 1) Primary outcome: right, left, both hip MI 2) Secondary outcomes: the hip and knee joint range of motion (ROM), pain intensity, satisfaction and discomfort score for the hip brace, quality of life (QOL) of the patients and their caregivers, and the wearability test.
Study Type
Interventional
Enrollment (Actual)
19
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gyeonggi-do
-
Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707
- Department of Rehabilitation Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 15 years (Child)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- diagnosis of cerebral palsy
- age 1-15 years
- GMFCS Level IV, V
- quadriplegia, or diplegia for more than 6 months
- Patients who have written consent with permission from the child and caregiver.
Exclusion Criteria:
- Patients who did not agree to participate in the study
- Patients who refused the examination
- Patients who had hip surgery experience
- Patients who were scheduled to undergo surgery during the clinical study
- Patients who could not be measured with a 3D scanner
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Severe cerebral palsy (GMFCS IV and V)
This study included patients with severe cerebral palsy (GMFCS IV and V)
|
Before starting the study, radiologic and clinical evaluation were performed.
After measuring the patient's exact physical size by applying a 3D scanner, we manufacture hip brace in preventing progressive hip displacement in patients with severe cerebral palsy.
After wearing for a week, follow-up radiologic and clinical evaluation were performed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Migration index
Time Frame: 1 weeks
|
Hip AP radiography
|
1 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Caregiver Priorities & Child Health Index of Life with Disabilities (CPCHILD)
Time Frame: 1 weeks
|
measure the quality of life expressed by score from 0 to 100.
The higher the quality of life.
|
1 weeks
|
|
Range of motion of hip joint
Time Frame: 1 weeks
|
Using goniometer, measure the hip and knee abduction and flexion angle expressed by degree from 0' to 180'.
The closer to 180', the better the value.
|
1 weeks
|
|
Visual analog scale (Pain index)
Time Frame: 1 weeks
|
measure the pain expressed by score from 0 to 10.
The closer to 10, the higher the pain.
|
1 weeks
|
|
Likert scale (score)
Time Frame: 1 weeks
|
measure the satisfaction, and discomfort about hip protection orthosis expressed by score from 1 to 5. The closer to 1, the higher the satisfaction or comfort.
|
1 weeks
|
|
wearability test
Time Frame: 1 weeks
|
the Wearability Test consisted of four questions on wearing sensation, five questions about on fit, and four questions on motion suitability evaluation.
Each item was scored on 5-point scale, with a total score of 65.
|
1 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Juseok Ryu, Seoul National University Bundang Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 2, 2022
Primary Completion (Actual)
January 31, 2023
Study Completion (Actual)
March 31, 2023
Study Registration Dates
First Submitted
May 12, 2022
First Submitted That Met QC Criteria
May 19, 2022
First Posted (Actual)
May 24, 2022
Study Record Updates
Last Update Posted (Actual)
May 1, 2023
Last Update Submitted That Met QC Criteria
April 27, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- E-2201-732-001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebral Palsy, Spastic
-
Suleyman Demirel UniversityCompletedCerebral Palsy | Hemiplegic Cerebral Palsy | Spastic Diplegia Cerebral PalsyTurkey (Türkiye)
-
Lahore University of Biological and Applied SciencesNot yet recruitingSpastic Diplegia Cerebral PalsyPakistan
-
Ankara City Hospital BilkentRecruitingCerebral Palsy (CP) | Cerebral Palsy, Spastic, Diplegic | Diplegic Cerebral Palsy With Spasticity | Transcranial Magnetic StimilationTurkey (Türkiye)
-
Beni-Suef UniversityNot yet recruitingUnilateral Spastic Cerebral Palsy
-
Cairo UniversityActive, not recruitingCerebral Palsy Spastic HemiplegicEgypt
-
Cairo UniversityCompletedCerebral Palsy Spastic HemiplegicEgypt
-
Gazi UniversityCompletedCerebral Palsy | Cerebral Palsy, Spastic | Cerebral Palsy Spastic Diplegia | Cerebral Palsy Quadriplegic | Cerebral Palsy, MonoplegicTurkey
-
Wroclaw University of Health and Sport SciencesNot yet recruitingSpastic Diplegia Cerebral Palsy | Spastic HemiplegiaPoland
-
TC Erciyes UniversityEnrolling by invitationCerebral Palsy (CP) | Spastic Diplegia Cerebral Palsy | Spastic Hemiplegic Cerebral PalsyTurkey
-
University of LahoreCompletedCerebral Palsy (CP) | Spastic Diplegia Cerebral Palsy | Balance | Gross Motor FunctionsPakistan